BioCentury | Nov 30, 2018
Company News

GEn1E gains rights to MUC1 IP

...with cystic fibrosis. University of Maryland Baltimore, Baltimore, Md. GEn1E Lifesciences Inc., Palo Alto, Calif. Business: Infectious Shannon Lehnbeuter Gen1E Lifesciences Inc. Mucin...
BioCentury | Oct 19, 2018
Company News

GEn1E gains option to p38 MAPK inhibitor

...distress syndrome (ALI/ARDS). GEn1E declined to disclose terms. The university did not respond to inquiries. GEn1E Lifesciences Inc....
Items per page:
1 - 2 of 2
BioCentury | Nov 30, 2018
Company News

GEn1E gains rights to MUC1 IP

...with cystic fibrosis. University of Maryland Baltimore, Baltimore, Md. GEn1E Lifesciences Inc., Palo Alto, Calif. Business: Infectious Shannon Lehnbeuter Gen1E Lifesciences Inc. Mucin...
BioCentury | Oct 19, 2018
Company News

GEn1E gains option to p38 MAPK inhibitor

...distress syndrome (ALI/ARDS). GEn1E declined to disclose terms. The university did not respond to inquiries. GEn1E Lifesciences Inc....
Items per page:
1 - 2 of 2